Nipro Renal Soultions USA, Corporation: MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201
Read the official notice at FDA (device) →
Get alerts for Nipro Renal Soultions
The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.
- Company / brand
- Nipro Renal Soultions USA, Corporation
- Product
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201
- Reason / hazard
- Hemodialysis concentrates contain high endotoxin levels
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
- Recall initiated
- 2026-08-05
- Code info
- BC-100 - Lot:N4L022 (exp.11/13/2026), N4L037(exp.11/18/2026) BC+201- Lot: N4L010(exp.11/06/2026)
- Product quantity
- 3,286 cases
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Lewisberry
- State
- PA
- Country
- United States
- Event id
- 99573
Free daily digest + "My products" watchlist